Evolent Health, Inc.
EVH
$4.20
$0.000.00%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.05B | 2.20B | 2.40B | 2.55B | 2.46B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.05B | 2.20B | 2.40B | 2.55B | 2.46B |
| Cost of Revenue | 1.68B | 1.84B | 2.03B | 2.19B | 2.07B |
| Gross Profit | 378.34M | 359.26M | 365.72M | 367.35M | 393.27M |
| SG&A Expenses | 273.63M | 261.44M | 254.57M | 246.64M | 244.43M |
| Depreciation & Amortization | 100.11M | 106.20M | 112.93M | 118.37M | 118.68M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.05B | 2.20B | 2.40B | 2.55B | 2.43B |
| Operating Income | 4.60M | -8.37M | -1.78M | 2.35M | 30.17M |
| Income Before Tax | -127.75M | -131.55M | -109.47M | -63.04M | -87.18M |
| Income Tax Expenses | 430.00K | -1.10M | -508.00K | -1.41M | -14.95M |
| Earnings from Continuing Operations | -128.18 | -130.45 | -108.96 | -61.62 | -72.23 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -128.18M | -130.45M | -108.96M | -61.62M | -72.23M |
| EBIT | 4.60M | -8.37M | -1.78M | 2.35M | 30.17M |
| EBITDA | 124.63M | 117.05M | 129.27M | 138.84M | 122.94M |
| EPS Basic | -1.57 | -1.61 | -1.22 | -0.81 | -0.91 |
| Normalized Basic EPS | -0.48 | -0.51 | -0.45 | -0.11 | 0.04 |
| EPS Diluted | -1.57 | -1.61 | -1.22 | -0.81 | -0.91 |
| Normalized Diluted EPS | -0.48 | -0.51 | -0.45 | -0.11 | 0.04 |
| Average Basic Shares Outstanding | 460.30M | 461.09M | 459.90M | 458.72M | 457.28M |
| Average Diluted Shares Outstanding | 460.30M | 461.09M | 459.90M | 458.72M | 457.28M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -12.43% | -14.67% | -17.97% | -32.59% | -28.30% |